# Candid Therapeutics

**Canonical:** https://apis.io/providers/candid-therapeutics/  
**Website:** https://www.candidrx.com/  
**APIs profiled:** 0

Candid Therapeutics is a San Diego, California clinical-stage biotechnology company developing T-cell engager (TCE) antibody therapies for autoimmune and inflammatory diseases. Launched publicly in September 2024 with a $370 million Series A financing and assembled by acquiring Vignette Bio and TRC 2004, Candid in-licenses differentiated bispecific TCE assets and advances them through US clinical development. Its approach redirects T-cells to selectively deplete autoreactive B-cells, aiming for deeper and more durable depletion than conventional antibody therapy without the manufacturing burden of cell therapy. Its lead investigational asset, cizutamig, is a BCMA x CD3 bispecific antibody. UCB completed its acquisition of Candid Therapeutics on 17 June 2026 for up to $2.2 billion ($2.0 billion upfront plus up to $200 million in milestones), and the company now operates as part of UCB. Candid Therapeutics publishes no public API, developer portal, SDK, or machine-readable specification.

## Kin Score — 6.9 / 100 (minimal)

Scored 2026-08-30 under rubric 0.17.2. Trend: flat (+0.0 from 6.9).

| Facet | Score |
|---|---|
| Discoverability | 57.4 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Commercial Clarity | 10.5 |
| Access Clarity | 10.5 |

Regulatory layer — **Health**: 12.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |
| Delegated Identity | no |
| Protected Resource Metadata | no |
| Dynamic Client Registration | no |
| Agentic Commerce | no |

## Security (1)

- **Candid Therapeutics Domain Security** — TLSv1.3 · DMARC

## Tags

Company, Biotechnology, Pharmaceuticals, Life Sciences, Immunology, Autoimmune Disease, Clinical Trials, Therapeutics, Antibodies, Drug Development

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/candid-therapeutics/). Scores are computed from the provider's own public artifacts under a published rubric.